Gout Relief 3310-s Capsule
NDC Package 85631-003-01
Package Information
Gout Relief 3310-s (celery seed, medicago sativa whole, chicory root) capsules is dissolved CrystallizationKidney StoneGallstone< Urinary Calculus. This formulation utilizes a capsule delivery system. Marketed by Bispit Canada Ltd., this product is identified by NDC 85631-003.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Grain Proteins - [EXT]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 85631 - Bispit Canada Ltd.
- 85631-003 - Gout Relief 3310-s
- 85631-003-01 - 60 CAPSULE in 1 BOX / 1.3 g in 1 CAPSULE
- 85631-003 - Gout Relief 3310-s
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85631-003-01 identifies a specific commercial package of 60 capsule in 1 box / 1.3 g in 1 capsule of Gout Relief 3310-s, a human over the counter drug labeled by Bispit Canada Ltd.. This capsule is formulated for oral use and contains buckwheat; celery seed; chicory root; glucosamine hydrochloride; licorice; medicago sativa whole; morus alba leaf; puerarin; sodium chloride; tea leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bispit Canada Ltd. on July 28, 2025. The current certification is valid through December 31, 2026.
How is this Bispit Canada Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85631000301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.